| Name | Title | Contact Details |
|---|---|---|
Felipe Baytelman |
Chief Technology Officer | Profile |
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Aura Medsystems is a Duxbury, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prior to Upward Health, Ward served as the Senior Vice President of Analytics at CareSource, a large health plan based in Ohio with multiple product lines in several states. Before CareSource, Ward held data and analytics leadership roles at a wide range of healthcare companies including Navvis, Corizon Health, naviHealth, and Centene. Ward brings to Upward Health a deep experience building prediction models, implementing business intelligence solutions, and driving process improvement through technology innovation.
Zoasis is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TriWest Healthcare Alliance is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.